Extract from the Register of European Patents

EP About this file: EP2991507

EP2991507 - COMPOSITION COMPRISING FISH OIL AND JUICE FOR USE IN THE TREATMENT OF CANCER [Right-click to bookmark this link]
Former [2016/10]USE OF A COMPOSITION COMPRISING FISH OIL AND JUICE FOR THE TREATMENT AND/OR POST TREATMENT OF CANCER
[2025/33]
StatusPatent maintained as amended
Status updated on  05.12.2025
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  05.07.2019
FormerGrant of patent is intended
Status updated on  27.03.2019
FormerExamination is in progress
Status updated on  25.05.2018
Most recent event   Tooltip05.12.2025Patent maintained (B2 publication)published on 07.01.2026  [2026/02]
Applicant(s)For all designated states
Smartfish AS
Gaustadallèen 21
0349 Oslo / NO
[2026/02]
Former [2016/10]For all designated states
Smartfish AS
Gaustadallèen 21
0349 Oslo / NO
Inventor(s)01 / MATHISEN, Janne Sande
c/o Smartfish AS
Gaustadallèen 21
N-0349 Oslo / NO
 [2016/10]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2026/02]
Former [2016/10]Zacco Norway AS
Haakon VII's gate 2
PO Box 2003 Vika
0125 Oslo / NO
Application number, filing date14726214.122.04.2014
[2016/10]
WO2014NO50061
Priority number, dateNO2013000055222.04.2013         Original published format: NO 20130552
[2016/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014175748
Date:30.10.2014
Language:EN
[2014/44]
Type: A1 Application with search report 
No.:EP2991507
Date:09.03.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 30.10.2014 takes the place of the publication of the European patent application.
[2016/10]
Type: B1 Patent specification 
No.:EP2991507
Date:07.08.2019
Language:EN
[2019/32]
Type: B2 New European patent specification 
No.:EP2991507
Date:07.01.2026
Language:EN
[2026/02]
Search report(s)International search report - published on:EP30.10.2014
ClassificationIPC:A23L5/00, A61K35/00, A23L33/105, A23L33/115, A61K31/202, A61K35/60, A61K36/00, A61K9/00, A61K9/107, A61P35/00
[2025/33]
CPC:
A61K31/202 (EP,US); A23L33/105 (EP,BR,US); A23L33/115 (EP,BR,US);
A61K35/60 (EP,US); A61K36/00 (EP,US); A61K47/36 (US);
A61K9/0095 (EP,US); A61K9/107 (EP,US); A61P35/00 (EP);
A23V2002/00 (EP,US) (-)
C-Set:
A61K36/00, A61K2300/00 (US,EP);
A23V2002/00, A23V2200/02, A23V2200/222, A23V2200/308, A23V2250/1868, A23V2250/187, A23V2250/1882, A23V2250/2106 (EP,US)
Former IPC [2016/10]A23L5/00, A61K35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/10]
TitleGerman:ZUSAMMENSETZUNG MIT FISCHÖL UND SAFT ZUR VERWENDUNG ZUR BEHANDLUNG VON KREBS[2025/33]
English:COMPOSITION COMPRISING FISH OIL AND JUICE FOR USE IN THE TREATMENT OF CANCER[2025/33]
French:COMPOSITION COMPRENANT DE L'HUILE DE POISSON ET DU JUS POUR L'UTILISATION POUR LE TRAITEMENT DU CANCER[2025/33]
Former [2016/10]VERWENDUNG EINER ZUSAMMENSETZUNG MIT FISCHÖL UND SAFT ZUR BEHANDLUNG UND/ODER NACHBEHANDLUNG VON KREBS
Former [2016/10]USE OF A COMPOSITION COMPRISING FISH OIL AND JUICE FOR THE TREATMENT AND/OR POST TREATMENT OF CANCER
Former [2016/10]UTILISATION D'UNE COMPOSITION COMPRENANT DE L'HUILE DE POISSON ET DU JUS POUR LE TRAITEMENT ET/OU LE POST-TRAITEMENT DU CANCER
Entry into regional phase20.11.2015National basic fee paid 
20.11.2015Designation fee(s) paid 
20.11.2015Examination fee paid 
Examination procedure11.02.2015Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.11.2015Examination requested  [2016/10]
14.06.2016Amendment by applicant (claims and/or description)
25.05.2018Despatch of a communication from the examining division (Time limit: M04)
23.08.2018Reply to a communication from the examining division
14.09.2018Despatch of a communication from the examining division (Time limit: M04)
15.01.2019Reply to a communication from the examining division
05.04.2019Communication of intention to grant the patent
24.06.2019Fee for grant paid
24.06.2019Fee for publishing/printing paid
24.06.2019Receipt of the translation of the claim(s)
Opposition(s)Opponent(s)01  22.04.2020    ADMISSIBLE
N.V. Nutricia
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Opponent's representative
Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
 [2020/22]
17.06.2020Invitation to proprietor to file observations on the notice of opposition
26.10.2020Reply of patent proprietor to notice(s) of opposition
12.01.2022Date of oral proceedings
10.02.2022Despatch of minutes of oral proceedings
10.02.2022Despatch of communication that the patent will be revoked
28.07.2025Despatch of interlocutory decision in opposition
28.07.2025Legal effect of interlocutory decision in opposition
05.11.2025Despatch of communication that the patent will be maintained as amended
Appeal following opposition19.04.2022Appeal received No.  T1057/22
19.04.2022Payment of appeal fee
20.06.2022Statement of grounds filed
24.04.2024Result of appeal procedure: maintenance in amended form
22.07.2024Despatch of the decision of the Board of Appeal
24.04.2024Date of oral proceedings
Fees paidRenewal fee
11.04.2016Renewal fee patent year 03
10.04.2017Renewal fee patent year 04
11.04.2018Renewal fee patent year 05
15.04.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
AT22.04.2024
CZ22.04.2024
GB22.04.2024
IT22.04.2024
SK22.04.2024
ES23.04.2024
CH30.04.2024
FR30.04.2024
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
[2025/33]
Former [2025/23]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
AT22.04.2024
CZ22.04.2024
GB22.04.2024
IT22.04.2024
SK22.04.2024
CH30.04.2024
FR30.04.2024
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
Former [2025/11]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
AT22.04.2024
CZ22.04.2024
GB22.04.2024
SK22.04.2024
CH30.04.2024
FR30.04.2024
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
Former [2025/10]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
AT22.04.2024
CZ22.04.2024
GB22.04.2024
SK22.04.2024
FR30.04.2024
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
Former [2025/09]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
AT22.04.2024
GB22.04.2024
FR30.04.2024
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
Former [2025/08]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
NL01.05.2024
PT22.10.2024
GR04.11.2024
DE05.11.2024
Former [2025/03]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
PT22.10.2024
Former [2022/33]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
BE30.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/32]AL07.08.2019
CY07.08.2019
MC07.08.2019
MK07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/27]AL07.08.2019
CY07.08.2019
MC07.08.2019
MT07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/21]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
IE22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
DK30.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/11]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
HR22.04.2021
LT22.04.2021
LV22.04.2021
HU23.04.2021
SE23.04.2021
SI23.04.2021
EE30.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/09]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
LT22.04.2021
HU23.04.2021
SE23.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/08]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
FI22.04.2021
LT22.04.2021
SE23.04.2021
NO30.04.2021
BG31.10.2021
Former [2022/07]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
LT22.04.2021
NO30.04.2021
Former [2021/08]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
LU22.04.2020
Former [2020/52]AL07.08.2019
MC07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
Former [2020/36]AL07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS07.12.2019
Former [2020/28]AL07.08.2019
RO07.08.2019
RS07.08.2019
SM07.08.2019
TR07.08.2019
IS24.02.2020
Former [2020/24]AL07.08.2019
RO07.08.2019
RS07.08.2019
TR07.08.2019
IS24.02.2020
Former [2020/23]AL07.08.2019
RO07.08.2019
RS07.08.2019
TR07.08.2019
IS07.12.2019
Former [2020/17]AL07.08.2019
RS07.08.2019
TR07.08.2019
IS07.12.2019
Former [2020/15]AL07.08.2019
RS07.08.2019
IS07.12.2019
Former [2020/13]RS07.08.2019
IS07.12.2019
Cited inInternational search[XI] WO2007064222  (PHARMALOGICA AS et al.)
 [A] WO2004075647  (BIOLI INNOVATION AS et al.)
 [A] WO2009120091  (PHARMALOGICA AS et al.)
by applicantNO324262
   WELSCH, CW, CANCER RES., vol. 52, 1992, pages 2040S - 2048S
   GLEISSMAN H. ET AL., EXPERIMENTAL CELL RESEARCH, vol. 316, 2010, pages 1365 - 1373
   TSENG, H. C. ET AL.: "Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells", PLOS ONE, vol. 5, no. 7, 2010, pages EL 1590
OppositionNO20130552
 WO2014175748
 WO2009120091
 WO03063793
 WO2007064222
   "Oxidation in Omega-3 Oils: An Overview", A WHITE PAPER PREPARED BY THE GLOBAL ORGANIZATION FOR EPA AND DHA OMEGA-3S AND THE COUNCIL FOR RESPONSIBLE NUTRITION, 1 January 2018 (2018-01-01), pages 1 - 7, XP055457336, Retrieved from the Internet
   NITURE, REFAI LUBNA: "PLANT PECTIN: A POTENTIAL SOURCE FOR CANCER SUPPRESSION", AMERICAN JOURNAL OF PHARMACOLOGY AND TOXICOLOGY, vol. 8, no. 1, 1 January 2013 (2013-01-01), pages 9 - 19, XP093007614, ISSN: 1557-4962, DOI: 10.3844/ajptsp.2013.9.19

DOI:   http://dx.doi.org/10.3844/ajptsp.2013.9.19
   SWAMI SHRIKANT BASLINGAPPA, THAKOR N. J., HALDANKAR P. M., KALSE S. B.: "Jackfruit and Its Many Functional Components as Related to Human Health: A Review", COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, vol. 11, no. 6, 1 November 2012 (2012-11-01), US , pages 565 - 576, XP055904399, ISSN: 1541-4337, DOI: 10.1111/j.1541-4337.2012.00210.x

DOI:   http://dx.doi.org/10.1111/j.1541-4337.2012.00210.x
   NGO SUONG N. T., WILLIAMS DESMOND B., HEAD RICHARD J.: "Rosemary and Cancer Prevention: Preclinical Perspectives", CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, vol. 51, no. 10, 1 December 2011 (2011-12-01), USA , pages 946 - 954, XP093007633, ISSN: 1040-8398, DOI: 10.1080/10408398.2010.490883

DOI:   http://dx.doi.org/10.1080/10408398.2010.490883
   DAVOODI H., ESMAEILI S., MORTAZAVIAN A.M.: "Effects of Milk and Milk Products Consumption on Cancer: A Review : Dairy products and cancer", COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, vol. 12, no. 3, 1 May 2013 (2013-05-01), US , pages 249 - 264, XP093007636, ISSN: 1541-4337, DOI: 10.1111/1541-4337.12011

DOI:   http://dx.doi.org/10.1111/1541-4337.12011
   YANG C ET AL.: "Does Vitamin E Prevent or Promote Cancer?", CANCER PREV RES (PHILA, vol. 5, no. 5, May 2012 (2012-05-01), pages 701 - 705, XP055459345, DOI: 10.1158/1940-6207.CAPR-12-0045

DOI:   http://dx.doi.org/10.1158/1940-6207.CAPR-12-0045
   FLEET C ET AL.: "Vitamin D and Cancer: A review of molecular mechanisms", BIOCHEM J., vol. 441, no. 1, 1 January 2012 (2012-01-01), pages 61 - 76
   KLLENBERG D ET AL.: "Health effects of dietary phospholipids", LIPIDS IN HEALTH AND DISEASE, vol. 11, 2012, pages 3, XP021118594, DOI: 10.1186/1476-511X-11-3

DOI:   http://dx.doi.org/10.1186/1476-511X-11-3
   FERLAY J., STELIAROVA-FOUCHER E., LORTET-TIEULENT J., ROSSO S., COEBERGH J.W.W., COMBER H., FORMAN D., BRAY F.: "Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012", EUROPEAN JOURNAL OF CANCER, vol. 49, no. 6, 1 April 2013 (2013-04-01), Amsterdam NL , pages 1374 - 1403, XP093007659, ISSN: 0959-8049, DOI: 10.1016/j.ejca.2012.12.027

DOI:   http://dx.doi.org/10.1016/j.ejca.2012.12.027
   ANONYMOUS: "Spis smart ved kreft", 23 November 2013 (2013-11-23), XP093007670, Retrieved from the Internet
   "Smartfish Nutrifriend 1100 - jackfruit and lychee flavouring", DATASHEET, 21 October 2010 (2010-10-21), XP093007679
   "Smartfish Nutifriend 1100", DATASHEET, 30 May 2012 (2012-05-30), XP093007680
   ANONYMOUS: "Smartfish Norway Nutrifriend 1100 | You Will Understand", 10 October 2012 (2012-10-10), XP093007681, Retrieved from the Internet
   CATTLEY RUSSELL C., RADINSKY BERT R.: "Cancer Therapeutics: Understanding the Mechanism of Action", TOXICOLOGIC PATHOLOGY, vol. 32, no. 1_suppl, 1 January 2004 (2004-01-01), US , pages 116 - 121, XP093007683, ISSN: 0192-6233, DOI: 10.1080/01926230490426507

DOI:   http://dx.doi.org/10.1080/01926230490426507
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.